Lung Cancer Squamous Cell
7 clinical trials · Condition
◉ Watch Lung Cancer Squamous Cell
| Record | Firm | Date |
|---|---|---|
| Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung (NCT04496674) | German Cancer Research Center | 2022-02-02 |
| Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung (NCT05228795) | Sohag University | 2022-02-01 |
| Electrocautery Ablation for the Prevention of Lung Cancer (NCT03870152) | University College, London | 2020-10-29 |
| Study of CT and MR in the Lung Cancer (NCT04034667) | Henan Cancer Hospital | 2019-09-01 |
| A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC (NCT03668496) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-09 |
| Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors (NCT03065062) | Dana-Farber Cancer Institute | 2017-02-28 |
Track Lung Cancer Squamous Cell automatically
Every clearance here is in the API, with alerts when new ones post.